OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding multifactorial architecture of Parkinson’s disease: pathophysiology to management
Ramandeep Kaur, Sidharth Mehan, Shamsher Singh
Neurological Sciences (2018) Vol. 40, Iss. 1, pp. 13-23
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Ewelina Pałasz, Adrianna Wysocka, Anna Gąsiorowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1170-1170
Open Access | Times Cited: 387

Parkinson’s Disease: A Review from Pathophysiology to Treatment
Bianca L. B. Marino, Lucilene Rocha de Souza, Kessia P.A. Sousa, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 20, Iss. 9, pp. 754-767
Closed Access | Times Cited: 169

Neuroprotective Effect of Chlorogenic Acid on Mitochondrial Dysfunction-Mediated Apoptotic Death of DA Neurons in a Parkinsonian Mouse Model
Saumitra Sen Singh, Sachchida Nand, Hareram Birla, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 138

Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases
Sarah Adriana Scuderi, Alessio Ardizzone, Irene Paterniti, et al.
Antioxidants (2020) Vol. 9, Iss. 7, pp. 630-630
Open Access | Times Cited: 88

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
Marika Cordaro, Salvatore Cuzzocrea, Rosalia Crupi
Antioxidants (2020) Vol. 9, Iss. 3, pp. 216-216
Open Access | Times Cited: 80

Tau in the Pathophysiology of Parkinson’s Disease
Lina Pan, Lanxia Meng, Mingyang He, et al.
Journal of Molecular Neuroscience (2021) Vol. 71, Iss. 11, pp. 2179-2191
Open Access | Times Cited: 74

Beneficial Effects of Spirulina Consumption on Brain Health
Teresa Trotta, Chiara Porro, Antonia Cianciulli, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 676-676
Open Access | Times Cited: 54

Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy
Dharmendra Kumar Khatri, Preeti Kumari, Shivraj Tonape, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 3, pp. 493-516
Open Access | Times Cited: 38

Role of Brain Liver X Receptor in Parkinson’s Disease: Hidden Treasure and Emerging Opportunities
Saud A. Alnaaim, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 1, pp. 341-357
Open Access | Times Cited: 28

The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
Y. So, Jae-Ung Lee, Ga-Seung Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1071-1071
Open Access | Times Cited: 11

Clinical features in Parkinson’s disease: characterization of urinary symptoms according to Parkinson disease subtype
Marilena Gubbiotti, Francesco Ditonno, Elona Brahimi, et al.
International Urology and Nephrology (2025)
Closed Access | Times Cited: 1

Cellular and Molecular Events Leading to Paraquat-Induced Apoptosis: Mechanistic Insights into Parkinson’s Disease Pathophysiology
Wesley Zhi Chung See, Rakesh Naidu, Kim San Tang
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3353-3369
Open Access | Times Cited: 37

Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors
Adriana Pérez‐González, Romina Castañeda‐Arriaga, Eduardo Gabriel Guzmán‐López, et al.
ACS Omega (2022) Vol. 7, Iss. 43, pp. 38254-38268
Open Access | Times Cited: 34

MicroRNA-gene regulatory network of TLR signaling in neuroinflammation-induced Parkinson’s disease: a bioinformatics approach
Gurpreet Singh, Dharmendra Kumar Khatri
Network Modeling Analysis in Health Informatics and Bioinformatics (2024) Vol. 13, Iss. 1
Closed Access | Times Cited: 7

Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models
Marina Trombetta-Lima, Angélica María Sabogal-Guáqueta, Amalia M. Dolga
Cell Calcium (2021) Vol. 94, pp. 102362-102362
Open Access | Times Cited: 38

Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders
Islauddin Khan, Preeti Kumari, Valencia Fernandes, et al.
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 7, pp. 2075-2095
Closed Access | Times Cited: 36

Hypoxia Signaling in Parkinson’s Disease: There Is Use in Asking “What HIF?”
Laura Lestón Pinilla, Aslihan Ugun‐Klusek, Sergio Rutella, et al.
Biology (2021) Vol. 10, Iss. 8, pp. 723-723
Open Access | Times Cited: 36

Protective effects of functional foods against Parkinson's disease: A narrative review on pharmacology, phytochemistry, and molecular mechanisms
Milad Iranshahy, Behjat Javadi, Amirhossein Sahebkar
Phytotherapy Research (2022) Vol. 36, Iss. 5, pp. 1952-1989
Closed Access | Times Cited: 25

Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways
Kajal Sherawat, Sidharth Mehan
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 8, pp. 1647-1667
Closed Access | Times Cited: 15

Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations
Swesha Chhabra, Sidharth Mehan, Zuber Khan, et al.
Journal of Neuroimmunology (2023) Vol. 384, pp. 578200-578200
Closed Access | Times Cited: 14

Traumatic brain injury and risk of Parkinson’s disease: a meta-analysis
Mohammad Balabandian, Maryam Noori, Behina Lak, et al.
Acta Neurologica Belgica (2023)
Closed Access | Times Cited: 13

Regulatory roles of the miR-200 family in neurodegenerative diseases
Jie Fu, Lilei Peng, Tao Tao, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 119, pp. 109409-109409
Open Access | Times Cited: 36

Apelin-13 Protects Dopaminergic Neurons against Rotenone—Induced Neurotoxicity through the AMPK/mTOR/ULK-1 Mediated Autophagy Activation
Peng Chen, Youcui Wang, Leilei Chen, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8376-8376
Open Access | Times Cited: 36

Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases
Saeideh Momtaz, Zahra Memariani, Fardous F. El‐Senduny, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 34

Page 1 - Next Page

Scroll to top